The ovarian insulin-like growth factors, a local amplification mechanism for steroidogenesis and hormone action.
The importance of the ovarian insulin-like growth factors (IGFs) has been suggested by data from numerous laboratories and several approaches in the last several years. In the aggregate, these data indicate that this system could function as an important local amplification mechanism for steroidogenesis and gonadotropin action. Studies supporting this hypothesis have described several interacting components of this autocrine/paracrine system. First, the several types of ovarian cells possess an IGF-response system, which includes receptors for IGFs and an effective intracellular transduction system. The IGFs can promote growth and/or differentiation of ovarian cells, and their predominant actions depend on the nature of the cells and the presence of additional modulating factors. The biochemical events leading to enhanced steroidogenesis are now understood in considerable detail and include induction of several steps in the cAMP-dependent steroidogenic cascade. The second component of the ovarian IGF system comprises hormone-responsive local production of IGFs. Both IGF-I and IGF-II may be secreted; gonadotropins, gonadal steroids and locally produced growth factors can regulate the IGF system at this level. Finally, ovarian cells secrete a heterogeneous and complex family of IGF-binding proteins (IGFBPs). These proteins can impact on multiple ovarian functions in a manner which is generally opposite to that of the IGFs themselves. As is the case for the IGFs, the secretion of these proteins by ovarian cells is regulated by gonadotropins and locally produced ovarian factors. Collectively, these several components provide an integrated, synergistically cooperative local network to promote gonadotropin-dependent growth and differentiation in the ovary.
Hammond
J M
JM
Department of Medicine, Milton S. Hershey Medical Center, Pennsylvania State University, Hershey 17033.
Mondschein
J S
JS
Samaras
S E
SE
Canning
S F
SF
D005260:Female; D006728:Hormones / Q000502:physiology*; D006801:Humans; D010053:Ovary / Q000378:metabolism*; D013002:Somatomedins / Q000378:metabolism / Q000502:physiology*; D013256:Steroids / Q000096:biosynthesis*
D006728:Hormones; D013002:Somatomedins; D013256:Steroids